Both in Pharmaceuticals
ProMIS Neurosciences Inc. Common Shares (ON) vs Impact BioMedical
Over the past year PMN returned −65.4% and IBO returned −39.0%; their daily moves had a correlation of 0.04.
PMN −65.4% IBO −39.0%Growth of $1, one year, split-adjusted
| Metric | PMN | IBO |
|---|---|---|
| Price | $3.52 | $4.10 |
| Market cap | $31.6M | $35.0M |
| Today | +3.23% | +1.99% |
| 1 month | −61.8% | −12.4% |
| 6 months | −68.0% | −48.8% |
| Year to date | −48.4% | −35.7% |
| 1 year | −65.7% | −39.0% |
| Revenue growth (YoY) | — | −57.1% |
| Gross margin | — | −533.3% |
| Net margin | — | −23300.0% |
| P/E (TTM) | — | 44.4× |
| Price / sales | — | 1,000.8× |
| Net cash | $53.5M | $10.0K |
| Dividend yield | — | — |
| Volatility (60d) | 262.2% | 736.6% |
| Short % of float | 3.3% | 2.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).